- Home
- HOOK
HOOK
HOOKIPA Pharma Inc.
as 12-23-2024 9:38am EST
HOOKIPA Pharma Inc is a clinical stage biopharmaceutical company developing a class of immunotherapeutics targeting infectious diseases and cancers based on its proprietary arenavirus platform that is designed to reprogram the body's immune system. It uses off-the-shelf technologies, VaxWave and TheraT, to elicit directly within patients a response of antigen-specific killer T cells and antibodies.
| Founded: | 2011 | Country: | United States |
| Employees: | N/A | City: | NEW YORK |
| Market Cap: | 25.8M | IPO Year: | 2019 |
| Target Price: | $23.00 | AVG Volume (30 days): | 64.0K |
| Analyst Decision: | Buy | Number of Analysts: | 4 |
| Dividend Yield: | N/A | Dividend Payout Frequency: | N/A |
| EPS: | -3.55 | EPS Growth: | N/A |
| 52 Week Low/High: | $1.88 - $10.50 | Next Earning Date: | 11-14-2024 |
| Revenue: | $49,999,000 | Revenue Growth: | 143.30% |
| Revenue Growth (this year): | 147.52% | Revenue Growth (next year): | -48.82% |
Latest HOOKIPA Pharma Inc. News
HOOK Breaking Stock News: Dive into HOOK Ticker-Specific Updates for Smart Investing
TipRanks
a month ago
Hookipa Pharma price target lowered to $7 from $24 at JMP Securities
TipRanks
a month ago
Hookipa Pharma announces workforce reduction of 80%, pause of eseba-vec program
MT Newswires
a month ago
Sector Update: Health Care Stocks Advance Late Afternoon
MT Newswires
a month ago
Sector Update: Health Care Stocks Climb Thursday Afternoon
MT Newswires
a month ago
HOOKIPA Pharma to Cut Workforce by 80%, Shift Focus to KRAS Cancer Program
Simply Wall St.
a month ago
Companies Like HOOKIPA Pharma (NASDAQ:HOOK) Could Be Quite Risky
Simply Wall St.
a month ago
HOOKIPA Pharma Third Quarter 2024 Earnings: EPS Beats Expectations, Revenues Lag
GlobeNewswire
a month ago
HOOKIPA Pharma Reports Third Quarter 2024 Financial Results and Provides Recent Business Updates
Compare HOOK vs Leading Stocks
Share on Social Networks:
Disclaimer
The information presented on this page, "HOOK HOOKIPA Pharma Inc. - Stocks Price | History | Analysis", including historical data, forecasts, news, insider information, and predictions, is provided for educational purposes only. It should not be considered as financial advice or a recommendation to buy or sell any securities. Decisions regarding investments should be made only after careful consideration and consultation with a qualified financial advisor. We do not endorse or guarantee the accuracy or reliability of the information provided, and we disclaim any liability for financial losses incurred as a result of decisions made based on the information presented.